Session # C-63

Experience of a Genetic Testing Laboratory with Customizable Hereditary Cancer Panels

  • Customizable panels are being used in various ways, from ordering all available genes, to adding/removing genes to/from an existing test.
  • While providers were more likely to select clinically-actionable genes, some genes without published management guidelines (BARD1, MRE11A, and RAD50) were ordered in half of custom panel cases.
  • Further investigation into the rationale for pursuing a custom panel, the reason genes are included or excluded, and the clinical histories of the tested patients is needed to better understand this testing approach.

  • Authors: Jessica Profato; Michelle Jackson; Holly LaDuca
  • Conference: NSGC 2017
  • Date: Friday, Sep 15, 2017 1:15pm - 2:30pm

Search Results

Start your search...